SARAH WAGNER: Open Payments
NPI 1700442738 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 15 payments from 9 companies in 2025. Trend: 2023 $56 · 2024 $321 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $69 |
| Amgen Inc. | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| Baxter Healthcare | 1 | $38 |
| Novo Nordisk Inc | 1 | $25 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: REZDIFFRA, TAVNEOS, JARDIANCE, Renal - Acute, Vanrafia, Fabhalta, Rybelsus, TARPEYO.
Industry payments across IN — which companies pay providers there.
